Asmanex HFA — Point32Health
maintenance treatment of asthma as prophylactic therapy
Preferred products
- Arnuity Ellipta
- Qvar RediHaler
Initial criteria
- The patient has had a trial of one Step‑1 medication (Arnuity Ellipta or Qvar RediHaler) as evidenced by a paid claim under the prescription benefit administered by the plan
- OR the patient has had a trial of a Step‑1 medication as evidenced by physician‑documented use, excluding the use of samples
- OR the requesting physician has documented that the patient has a contraindication to or is unable to tolerate medications on Step‑1